Requires NJ FamilyCare to reimburse inpatient providers for long-acting injectable antipsychotic drugs at outpatient reimbursement rate.
S 3837 mandates NJ FamilyCare reimburse inpatient psychiatric providers at outpatient rates for long-acting injectable antipsychotics, potentially reducing state costs but risking provider access and treatment continuity.